Ophthalmology Doctors in Mount Vernon, NY Accepting Medicare

8 Ophthalmology doctors found. Showing 1 - 8

Seth A Biser, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 654 Gramatan Ave, Mount Vernon, NY 10552 Phone: 914-664-2300

Dr. Amir Yamani, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 153 Stevens Ave, Suite 6, Mount Vernon, NY 10550 Phone: 914-667-3800    Fax: 914-667-3812

Maryam Yamani, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 153 Stevens Ave, Mount Vernon, NY 10550 Phone: 914-667-3800    Fax: 914-667-3812

Ravi Radhakrishnan, MD Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 559 Gramatan Ave Ste 202, Mount Vernon, NY 10552 Phone: 914-699-2020    Fax: 914-699-2019

Mr. Milton Delerme, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 107 West 4th Street, Mount Vernon Neighborhood Health Center, Mount Vernon, NY 10550 Phone: 914-699-7200    Fax: 914-699-0837

Dr. Theodore J Sifontes, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 107 W 4th St, Mount Vernon, NY 10550 Phone: 914-699-7200    Fax: 914-699-0837

Paul Mario Mignone, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 202 Stevens Ave, Mount Vernon, NY 10550 Phone: 914-664-6001

Mr. Michael David Boron, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 107 West 4th Street, Mount Vernon Neighborhood Health Center, Mount Vernon, NY 10550 Phone: 914-699-7200    Fax: 914-699-0837

News Archive

Pfizer's palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Pfizer Inc. today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib and letrozole compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or newly diagnosed metastatic breast cancer.

Access Systems awarded $3.5M contract to support HHS FTS2001-Networx Transition Program Management Office

Access Systems, Inc. (ACCESS), an information technology (IT) solutions provider, has been awarded a $3.5M contract by GSA's National Capital Region to support the Department of Health and Human Services (HHS) FTS2001-Networx Transition Program Management Office. ACCESS and team partner, BCCP Consulting, LLC, will assist HHS to conduct Fair Opportunity for selecting the Networx vendors that will provide telecommunications and associated professional services to the HHS OPDIVs.

Exercise and the exam room: Kaiser Permanente, other providers record new vital sign

Kaiser Permanente, one of the nation's largest nonprofit health insurance plans, made a big push a few years ago to get its southern California doctors to ask patients about exercise.

Experts develop new framework for productive aging of workforce

With unprecedented demographic trends leading to an aging workforce, a new emphasis on productive aging is needed to keep US workers of all generations as healthy and productive as possible, according to an article in the May Journal of Occupational and Environmental Medicine.

Study shows nutrition has a direct influence on the immune system

Bonn researchers have discovered an elementary mechanism which regulates vital immune functions in healthy people. In situations of hunger which mean stress for the body's cells, the body releases more antimicrobial peptides in order to protect itself. The scientists will publish their results in the journal Nature.

Read more Medical News

› Verified 5 days ago